Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 08:50 am Purchase | 2024-02-08 | 13G | Cartesian Therapeutics, Inc. RNAC | FMR LLC | 441,879 8.186% | 441,879 (New Position) | Filing History |
| 2023-11-22 4:39 pm Purchase | 2023-11-13 | 13D | Cartesian Therapeutics, Inc. RNAC | Singer Michael | 868,698 13.900% | 868,698 (New Position) | Filing History |
| 2023-11-22 4:38 pm Purchase | 2023-11-13 | 13D | Cartesian Therapeutics, Inc. RNAC | Kalayoglu Murat | 1,311,482 19.900% | 1,311,482 (New Position) | Filing History |
| 2023-11-17 08:15 am Purchase | 2023-11-13 | 13D | Cartesian Therapeutics, Inc. RNAC | SPRINGER TIMOTHY A | 6,431,355 27.700% | 4,952,803 (+334.98%) | Filing History |
| 2023-09-22 7:31 pm Purchase | 2022-04-11 | 13D | Cartesian Therapeutics, Inc. RNAC | SPRINGER TIMOTHY A | 1,478,553 28.900% | 389,789 (+35.80%) | Filing History |
| 2023-06-12 4:30 pm Purchase | 2023-06-01 | 13G | Cartesian Therapeutics, Inc. RNAC | Artal Participations S.a r.l | 340,233 6.600% | 340,233 (New Position) | Filing History |
| 2023-02-14 1:45 pm Purchase | 2022-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | Mangrove Partners IM, LLC | 312,923 5.970% | 33,726 (+12.08%) | Filing History |
| 2022-07-27 4:37 pm Purchase | 2022-05-13 | 13G | Cartesian Therapeutics, Inc. RNAC | Mangrove Partners IM, LLC | 279,197 5.370% | 12,500 (+4.69%) | Filing History |
| 2022-05-23 5:39 pm Purchase | 2022-05-13 | 13G | Cartesian Therapeutics, Inc. RNAC | Mangrove Partners IM, LLC | 266,697 5.140% | 3,971 (+1.51%) | Filing History |
| 2022-05-09 3:23 pm Sale | 2022-04-30 | 13G | Cartesian Therapeutics, Inc. RNAC | BlackRock Inc. BLK | 226,876 4.500% | -4,853 (-2.09%) | Filing History |
| 2022-02-14 1:18 pm Sale | 2021-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | BIOTECHNOLOGY VALUE FUND L P | 57,438 1.500% | -106,766 (-65.02%) | Filing History |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | BlackRock Inc. BLK | 231,729 6.000% | 49,252 (+26.99%) | Filing History |
| 2021-12-27 4:05 pm Purchase | 2021-12-15 | 13D | Cartesian Therapeutics, Inc. RNAC | SPRINGER TIMOTHY A | 1,088,764 28.000% | 7,040 (+0.65%) | Filing History |
| 2021-12-15 5:14 pm Purchase | 2021-12-09 | 13D | Cartesian Therapeutics, Inc. RNAC | SPRINGER TIMOTHY A | 1,081,724 27.800% | 127,376 (+13.35%) | Filing History |
| 2021-05-27 4:11 pm Purchase | 2021-05-21 | 13D | Cartesian Therapeutics, Inc. RNAC | SPRINGER TIMOTHY A | 954,348 25.300% | 156,449 (+19.61%) | Filing History |
| 2021-02-16 12:03 pm Purchase | 2020-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | Mangrove Partners Master Fund Ltd. | 111,097 3.000% | 111,097 (New Position) | Filing History |
| 2021-02-12 5:19 pm Sale | 2020-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | EcoR1 Capital, LLC | 76,628 2.100% | -153,257 (-66.67%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | BlackRock Inc. BLK | 182,477 5.100% | 182,477 (New Position) | Filing History |